Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01491113
What this trial is testing

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Who this might be right for
Healthy SubjectsRenal Impairments
UCB Pharma 30
Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT02436447
What this trial is testing

Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

Who this might be right for
Normal and Impaired Renal Function
Stealth BioTherapeutics Inc. 23
Post-approval studies (Phase 4)Not Yet RecruitingNCT07345689
What this trial is testing

The Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

Who this might be right for
Hepatic InsufficiencyRenal InsufficiencyElderly
Xuanzhu Biopharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT05012436
What this trial is testing

Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Who this might be right for
Healthy VolunteerRenal Impairments
Yuhan Corporation 16
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT00833716
What this trial is testing

Effect of Renal Impairment on the Pharmacokinetics of NN9535

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Renal Impairment
Novo Nordisk A/S 62
Large-scale testing (Phase 3)Study completedNCT03819153
What this trial is testing

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,533
Testing effectiveness (Phase 2)Study completedNCT03180619
What this trial is testing

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 124
Early research (Phase 1)Study completedNCT01537757
What this trial is testing

A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 12
Early research (Phase 1)Study completedNCT01393964
What this trial is testing

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 35
Early research (Phase 1)Study completedNCT06496217
What this trial is testing

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal Impairment
MBX Biosciences 25
Large-scale testing (Phase 3)Study completedNCT00364260
What this trial is testing

A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.

Who this might be right for
AnemiaKidney FailureLeft Ventricular Hypertrophy
Janssen-Ortho Inc., Canada 172
Early research (Phase 1)Study completedNCT02275156
What this trial is testing

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Amgen 18
Early research (Phase 1)Study completedNCT00674856
What this trial is testing

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

Who this might be right for
Renal Failure
NicOx 32
Post-approval studies (Phase 4)Ended earlyNCT00785772
What this trial is testing

A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1
Large-scale testing (Phase 3)Study completedNCT01785875
What this trial is testing

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 891
Early research (Phase 1)Study completedNCT01975337
What this trial is testing

Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects

Who this might be right for
Kidney Failure, Chronic
Debiopharm International SA 16
Not applicableLooking for participantsNCT07115953
What this trial is testing

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Who this might be right for
HypertensionVascular DiseasesCardiovascular Diseases+2 more
Medtronic Vascular 130
Early research (Phase 1)Study completedNCT00472836
What this trial is testing

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Who this might be right for
Obesity
Pfizer 17
Next Page